Study on the Diagnostic Efficacy of ICL Selection and Prediction Depth Model Based on Eye Images
Launched by SECOND AFFILIATED HOSPITAL OF NANCHANG UNIVERSITY · Oct 30, 2024
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new method using advanced computer technology, called a deep neural network, to help doctors choose the best implantable collamer lenses for people with myopia (nearsightedness). The goal is to see how well this technology can predict which lenses will work best for each patient. The study is currently looking for participants aged 18 to 45 years who have stable vision and meet certain health criteria.
To be eligible, you should have myopia with or without astigmatism, and your eye measurements must fall within specific ranges. If you decide to join the study, you can expect to undergo eye examinations and assessments to determine if you qualify. It’s important to know that individuals with certain eye conditions or those who have had specific eye surgeries may not be able to participate. Overall, this trial aims to improve how we select lenses to give patients better vision results.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Aged 18-45 years ;
- • 2. Myopia, with or without astigmatism, annual diopter change ≤ 0.50 D for 2 consecutive years ;
- • 3. Anterior chamber depth ≥ 2.80 mm ;
- • 4. Corneal endothelial cell count ≥ 2000 / mm2, stable cell morphology ;
- • 5. There were no other ocular diseases that significantly affected vision and / or systemic organic lesions that affected surgical recovery.
- Exclusion Criteria:
- • 1. There were no other ocular diseases that significantly affected vision and / or systemic organic lesions that affected surgical recovery;
- • 2. Have a history of corneal refractive surgery or intraocular surgery ;
- • 3. Corneal endothelial cell count is low ;
- • 4. Those with systemic diseases ;
- • 5. Lactating or pregnant women.
About Second Affiliated Hospital Of Nanchang University
The Second Affiliated Hospital of Nanchang University is a leading medical institution dedicated to advancing healthcare through innovative clinical research and patient care. As a prominent sponsor of clinical trials, the hospital combines its extensive clinical expertise with a commitment to ethical research practices, aiming to enhance treatment options and improve patient outcomes. With a focus on collaboration and multidisciplinary approaches, the hospital engages in a wide range of studies across various medical fields, contributing to the global body of medical knowledge and fostering advancements in health science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nanchang, Jiangxi, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported